Clinical Perspectives on Using Remote Measurement Technology in Assessing Epilepsy, Multiple Sclerosis, and Depression: Delphi Study
JMIR Neurotechnology2023Vol. 2, pp. e41439–e41439
Citations Over TimeTop 13% of 2023 papers
Jacob A Andrews, Michael P. Craven, Boliang Guo, Janice Weyer, Simon Lees, Spyridon I Zormpas, Sarah Thorpe, Julie Devonshire, Victoria San Antonio‐Arce, William Whitehouse, Jessica Julie, Sam Malins, Alexander Hammers, Andreas Reif, Henricus G. Ruhé, Federico Durbano, Sergio Barlati, Arjune Sen, Jette Lautrup Frederiksen, Alessandra Martinelli, Antonio Callén, Joan Torras-Borrell, Nuria Berrocal‐Izquierdo, Ana Zabalza, Richard Morriss, Chris Hollis
Abstract
Overall, these findings inform the prioritization of use cases for RMT that could be developed in future work, which may include clinical trials, cost-effectiveness studies, and the commercial development of RMT products and services. Priorities for further development include the use of RMT to provide more accurate records of symptoms and treatment response than is currently possible and to provide data that could help inform patient triage and generate timely alerts for patients and carers.
Related Papers
- → Enhancing a Delphi study on family-focused prevention(2006)49 cited
- → An analysis of prior delphi applications and some observations on its future applicability(1977)35 cited
- → Applications of the Delphi method in China(1990)12 cited
- → FACULTY CONSENSUS AT A MULTI‐CAMPUS COLLEGE THROUGH DELPHI(1988)9 cited
- → A Delphi Study of Regional Industrial Land-Use(1977)4 cited